The targeted protein degradation enabling technologies market | #targeted Protein Degradation Market #protein degradation

The targeted protein degradation enabling technologies market

Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare

CHALLENGES AND OPPORTUNITIES FOR CELL LINE DEVELOPMENT AND CHARACTERIZATION SERVICE PROVIDERS | #cell lines # cell line development # cell line characterization # cell line development market # cell line development market size

CHALLENGES AND OPPORTUNITIES FOR CELL LINE DEVELOPMENT AND CHARACTERIZATION SERVICE PROVIDERS

In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies.

The pharmaceutical secondary packaging market | #pharmaceutical packaging # pharmaceutical packaging market # secondary packaging # pharmaceutical packaging industry

The pharmaceutical secondary packaging market

In order to avail benefits, such as higher flexibility, reduced cost and assistance in meeting the rising demands, several pharmaceutical companies have demonstrated a preference to outsource their secondary packaging requirements to contract packaging organizations

The contract regulatory affairs-management services market for medical | #medical device Cro # Medical device cro market # Medical device cro companies # cro medical device

The contract regulatory affairs-management services market for medical

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market

The Herceptin® biosimilars market is projected to witness considerable growth over the coming years | #trastuzumab biosimilar

The Herceptin® biosimilars market is projected to witness considerable growth over the coming years

Herceptin® sales peaked in 2018, a year before the primary patent covering the drug expired in the US; in order to carve out a share of the associated opportunity, stakeholders in the pharma industry have long been developing follow on products